Literature DB >> 18332667

Redefining (somatoform) pain disorder in ICD-10: a compromise of different interest groups in Germany.

Winfried Rief1, Michael Zenz, Ullrich Schweiger, Heinz Rüddel, Peter Henningsen, Paul Nilges.   

Abstract

PURPOSE OF REVIEW: Pain is one of the most frequent reasons to visit health professionals. Many patients suffering from chronic pain conditions not only need medical treatment but also psychiatric or psychological interventions. This additional treatment need should be underlined using an ICD section F diagnosis. The current ICD-10 diagnosis of somatoform pain disorder requests psychological causation of the pain, which is frequently unclear or difficult to decide. RECENT
FINDINGS: In Germany, the different interest groups, namely of psychiatry, pain research, psychosomatic medicine and clinical psychology, met to find a consensus on how to re-classify pain disorder under section F of ICD-10. This manuscript summarizes the result.
SUMMARY: A diagnosis of pain disorder is necessary to underline the additional need of psychiatric/psychological interventions in chronic pain conditions. This diagnosis should include psychological features that are relevant for development or maintenance of chronic pain. In contrast to earlier attempts of redefining pain diagnoses, our attempt included representatives of the association for the study of pain.

Entities:  

Mesh:

Year:  2008        PMID: 18332667     DOI: 10.1097/YCO.0b013e3282f4cdf2

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  15 in total

1.  [Coding chronic pain in ICD-10].

Authors:  R-D Treede; G Müller-Schwefe; R Thoma
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

Review 2.  [Symptom and complaint validation of chronic pain in social medical evaluation. Part I: Terminological and methodological approaches].

Authors:  R Dohrenbusch
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

3.  [New pain diagnosis in the German version of the ICD-10].

Authors:  W Rief; R-D Treede; U Schweiger; P Henningsen; H Rüddel; P Nilges
Journal:  Nervenarzt       Date:  2009-03       Impact factor: 1.214

4.  [Chronic pain in general practice : Results from pain specialists].

Authors:  A Heymanns; H Rudolf; H Schneider-Nutz; K Salem; K Strick; M Zenz
Journal:  Schmerz       Date:  2017-08       Impact factor: 1.107

5.  [Chronic pain in German medical practices. Current demands placed on the primary health care system due to pain prevalence].

Authors:  C H Friessem; A Willweber-Strumpf; M W Zenz
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

6.  [Chronic pain disorder with somatic and psychological factors : A diagnosis initiated by professional politics awaits its scientific validation].

Authors:  W Häuser
Journal:  Schmerz       Date:  2018-06       Impact factor: 1.107

7.  [Diagnosis F45 is scientifically reliable].

Authors:  P Nilges; W Rief; U Kaiser; J Lutz; M Pfingsten; B Arnold
Journal:  Schmerz       Date:  2018-06       Impact factor: 1.107

Review 8.  [Definition, diagnostics and therapy of chronic widespread pain and the (so-called) fibromyalgia syndrome in children and adolescents : Updated guidelines 2017].

Authors:  N Draheim; F Ebinger; E Schnöbel-Müller; B Wolf; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

Review 9.  [Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Systematic literature review and guideline].

Authors:  B Zernikow; K Gerhold; G Bürk; W Häuser; C H Hinze; T Hospach; A Illhardt; K Mönkemöller; M Richter; E Schnöbel-Müller; R Häfner
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

10.  [Administrative prevalence, treatment and costs of somatoform pain disorder. Analysis of data of the BARMER GEK for the years 2008-2010].

Authors:  W Häuser; U Marschall; H L'hoest; K Komossa; P Henningsen
Journal:  Schmerz       Date:  2013-08       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.